Destrin (DSTN)

Destrin (DSTN) is an actin-binding and actin-severing protein, a key member of the ADF/cofilin family responsible for regulating actin filament turnover and cytoskeletal remodeling. It severs actin filaments (F-actin) and binds actin monomers (G-actin) in a pH-independent manner, promoting dynamic reorganization of the cytoskeleton necessary for migration, proliferation, and phenotypic modulation in smooth muscle and other cell types. DSTN activity is regulated by upstream signaling pathways such as RhoA, SRF, and TGF-beta, with its expression selectively upregulated or downregulated depending on context. Dysregulation of DSTN is implicated in various cancers—affecting proliferation and invasion—and in cardiovascular pathologies such as atherosclerosis and restenosis through modulation of smooth muscle cell differentiation and migration. The molecule is an attractive research target for understanding cytoskeletal dynamics and disease mechanisms, but currently has no approved drugs or recognized biomarker application in the clinic.

Other names

Actin-depolymerizing factorADFDSNACTDPHEL32Epididymis luminal protein 32Epididymis secretory sperm binding proteinbA462D18.2Destrin, actin depolymerizing factor

Not applicable for currently approved drugs; mechanism for potential targeting would involve inhibition or modulation of actin-severing and actin-monomer-binding functions. Potential RNA interference (siRNA) strategies for knockdown as shown in experimental settings.